• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis
 
  • Details
  • Full
Options
2016
Journal Article
Title

Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis

Abstract
MicroRNA are well-established players in post-transcriptional gene regulation. However, information on the effects of microRNA deregulation mainly relies on bioinformatic prediction of potential targets, whereas proof of the direct physical microRNA/target messenger RNA interaction is mostly lacking. Within the International Cancer Genome Consortium Project ""Determining Molecular Mechanisms in Malignant Lymphoma by Sequencing"", we performed miRnome sequencing from 16 Burkitt lymphomas, 19 diffuse large B-cell lymphomas, and 21 follicular lymphomas. Twentytwo miRNA separated Burkitt lymphomas from diffuse large B-cell lymphomas/follicular lymphomas, of which 13 have shown regulation by MYC. Moreover, we found expression of three hitherto unreported microRNA. Additionally, we detected recurrent mutations of hsa-miR-142 in diffuse large B-cell lymphomas and follicular lymphomas, and editing of the hsa-miR-376 cluster, providing evidence for microRNA editing in lymphomagenesis. To interrogate the direct physical interactions of microRNA with messenger RNA, we performed Argonaute-2 photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation experiments. MicroRNA directly targeted 208 messsenger RNA in the Burkitt lymphomas and 328 messenger RNA in the non-Burkitt lymphoma models. This integrative analysis discovered several regulatory pathways of relevance in lymphomagenesis including Ras, PI3KAkt and MAPK signaling pathways, also recurrently deregulated in lymphomas by mutations. Our dataset reveals that messenger RNA deregulation through microRNA is a highly relevant mechanism in lymphomagenesis.
Author(s)
Hezaveh, Kebria
Universität Düsseldorf
Kloetgen, Andreas
Universität Düsseldorf
Bernhart, Stephan H.
Universität Leipzig
Mahapatra, Kunal Das
Universität Düsseldorf
Lenze, Dido
Charité Berlin
Richter, Julia
Universität Kiel
Haake, Andrea
Universität Kiel
Bergmann, Anke K.
Universität Kiel
Brors, Benedikt
DKFZ, Heidelberg
Burkhardt, Birgit
Universitätsklinikum Münster
Claviez, Alexander
Universitätsklinikum Schleswig-Holstein
Drexler, Hans G.
DSMZ, Braunschweig
Eils, Roland
Universität Heidelberg
Haas, Siegfried
Friedrich-Ebert Klinikum Neumünster
Hoffmann, Steve
Universität Leipzig
Karsch, Dennis
Universitätsklinikum Schleswig-Holstein
Klapper, Wolfram
Universität Kiel
Kleinheinz, Kortine
DKFZ, Heidelberg
Korbel, Jan
EMBL Heidelberg
Kretzmer, Helene
Universität Leipzig
Kreuz, Markus
IMISE Leipzig
Küppers, Ralf
Universität Duisburg-Essen
Lawerenz, Chris
DKFZ, Heidelberg
Leich, Ellen
Universität Würzburg
Loeffler, Markus
IMISE Leipzig
Mantovani-Loeffler, Luisa
Klinikum St. Georg, Leipzig
López, Cristina
Universität Kiel
McHardy, Alice C.
Universität Düsseldorf
Möller, Peter
Universität Ulm  
Rohde, Marius
Universitätsklinikum Giessen
Rosenstiel, Philip
Universität Kiel
Rosenwald, Andreas
Universität Würzburg
Schilhabel, Markus
Universität Kiel
Schlesner, Matthias
Universität Kiel
Scholz, Ingrid
DKFZ, Heidelberg
Stadler, Peter F.
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Stilgenbauer, Stephan
Universität Ulm  
Sungalee, Stéphanie
EMBL Heidelberg
Szczepanowski, Monika
Universität Kiel
Trümper, Lorenz
Universität Göttingen
Weniger, Marc A.
Universität Duisburg-Essen
Siebert, Reiner
Universität Kiel
Borkhardt, Arndt
Universität Düsseldorf
Hummel, Michael
Charité Berlin
Hoell, Jessica I.
Universität Düsseldorf
Journal
Haematologica  
Open Access
DOI
10.3324/haematol.2016.143891
Additional link
Full text
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024